Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rurina Watanuki
Observed names:
R Watanuki,
R. Watanuki,
R., Watanuki,
Rurina WATANUKI,
Watanuki, Rurina
Institution:
National Cancer Center Hospital East
Observed institutions:
Keio University,
Keio University Hospital,
National Cancer Center Hospital East,
National Cancer Center Hospital,
Kawasaki Municipal Ida Hospital,
National Cancer Center Hospital
show all 6
ORCID:
0000-0002-7462-4137
Observed ORCID:
0000-0002-7462-4137
OpenAlex ID:
A5083789269
The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer
2017
·
Ayako Nakashoji
, Tetsu Hayashida
, et al.
·
Cancer Treatment Reviews
·
23
IgG4‐related mastopathy: A case report and literature review
2018
·
Takamichi Yokoe
, Tetsu Hayashida
, et al.
·
Clinical Case Reports
·
21
PDF
Establishment of a deep‐learning system to diagnose BI‐RADS4a or higher using breast ultrasound for clinical application
2022
·
Tetsu Hayashida
, Erina Odani
, et al.
·
Cancer Science
·
20
Pathologic method for extracting good prognosis group in triple‐negative breast cancer after neoadjuvant chemotherapy
2022
·
Yuki Eguchi
, Tokiko Nakai
, et al.
·
Cancer Science
·
9
PDF
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)
2020
·
Hinako Maeda
, Tetsu Hayashida
, et al.
·
Breast Cancer
·
7
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)
2025
·
Rurina Watanuki
, Hitomi Sakai
, et al.
·
Breast Cancer
·
6
PDF
Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score‐matched analysis of SEER data
2020
·
Rurina Watanuki
, Tetsu Hayashida
, et al.
·
The Breast Journal
·
5
PDF
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients
2019
·
Rurina Watanuki
, Tetsu Hayashida
, et al.
·
International Journal of Clinical Oncology
·
5
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
2025
·
Chikako Funasaka
, Takahiro Kogawa
, et al.
·
Cancer Treatment and Research Communications
·
4
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
2020
·
Rurina Watanuki
, Akihiko Shimomura
, et al.
·
Medicine
·
3
Abstract P1-02-09: Diagnostic system of breast ultrasound images using Convolutional Neural Network
2020
·
Masayuki Kikuchi
, Tetsu Hayashida
, et al.
·
Cancer Research
·
3
Identification of a Modified HOXB9 mRNA in Breast Cancer
2020
·
Ayako Nakashoji
, Tetsu Hayashida
, et al.
·
Journal of Oncology
·
2
PDF
Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis
2024
·
Naoki Miyazaki
, Toshiki Iwasaki
, et al.
·
Current Medical Research and Opinion
·
1
PDF
Abstract P1-05-06: Establishment of the breast ultrasound support system using deep-learning system
2023
·
Erina Odani
, Tetsu Hayashida
, et al.
·
Cancer Research
·
1
A Case of Brachial Lymph Node Recurrences after the Resection of Locally Advanced Breast Cancer
2022
·
Kayono Onishi
, Rurina Watanuki
, et al.
·
Case Reports in Oncology
·
1
Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course
2026
·
Asako Yamamoto
, Rurina Watanuki
, et al.
·
Case Reports in Oncology
PDF
Supplemental Material for: Case Report Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course
2026
·
figshare admin karger
, Asako Yamamoto
, et al.
·
Figshare
Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B)
2026
·
Rurina Watanuki
, Hitomi Sakai
, et al.
·
Breast Cancer
2898P The efficacy of lemborexant for insomnia comorbid with breast cancer: A prospective observational study (WJOG14921B, LUNAR study)
2025
·
Y. Ozaki
, M. Hosonaga
, et al.
·
Annals of Oncology
O5-2 WJOG (West Japan Oncology Group) Breast Cancer Consensus Meeting 2023
2024
·
Y. Kimura
, R. Watanuki
, et al.
·
Annals of Oncology
PDF
MO63-4 Utility of IHC-based markers for predicting pathological complete response in early-stage triple-negative breast cancer
2024
·
C. Funasaka
, T. Kogawa
, et al.
·
Annals of Oncology
PDF
A comparative analysis of BI-RADS and the Japanese Recall Criteria and Categorization in breast ultrasound screening
2023
·
Tetsu Hayashida
, Aiko Nagayama
, et al.
·
Research Square
PDF
[A Case of Triple Negative Breast Cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
2023
·
Nobushige Yabe
, Rurina Watanuki
, et al.
·
PubMed
Prospective observational study to evaluate lemborexant utility in insomnia among women with breast cancer (WJOG14921B, LUNAR study).
2023
·
Yukinori Ozaki
, Mari Hosonaga
, et al.
·
Journal of Clinical Oncology
Supplementary Material for: A Case of Brachial Lymph Node Recurrences after the Resection of Locally Advanced Breast Cancer
2022
·
K., Onishi
, R., Watanuki
, et al.
·
Figshare
Show more works
View as search
Works count:
34
Citation count:
111
H-index:
6
I10-index:
3
Year
Topic
Type